Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $125.1, ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Summit Therapeutics (SMMT – Research Report).

Truist Financial analyst Michael Ciarmoli maintained a Buy rating on Northrop Grumman (NOC – Research Report) today and set a price target of ...

Combining Trodelvy with Keytruda and pushing it into the frontline setting could “potentially double” the ADC’s market in ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Chris Rokos. In this article, we are going to ...

Chris Rokos is a highly respected British hedge fund manager who co-founded Brevan Howard Asset Management in 2002 before departing to establish his own firm in 2015, Rokos Capital Management, which ...

Truist shares offer a 5.8% dividend yield and a value opportunity with a sub-10x multiple. Click here to read why TFC stock ...

Strong cost management drives positive leverage despite a revenue dip. Read more on my updated look at the latest TFC ...

Truist Securities raised its rating on Element Solutions (NYSE:ESI) from Hold to Buy, setting a new price target of $24, down from $28, citing the company’s strong fundamentals and strategic ...

Fintel reports that on April 14, 2025, Truist Securities upgraded their outlook for Element Solutions (NYSE:ESI) from Hold to ...

Fintel reports that on April 10, 2025, Truist Securities upgraded their outlook for Public Storage - Preferred Stock ...

Truist Securities analyst William Stein initiated coverage on MACOM Technology Solutions Holdings with a Buy rating and $125 price target, citing growth in RF and similar components and recent ...